“FDA approved” appears on more aesthetics and wellness marketing than almost any other phrase, and a large share of the time it is being used incorrectly — sometimes carelessly, sometimes deliberately.
The distinctions below are not pedantic. They determine what you may legally say, what you may legally sell, and what happens if a regulator reads your website.
The four categories that get confused
| Term | What it actually means |
|---|---|
| FDA approved | The FDA reviewed safety and effectiveness data for a specific product, for a specific indication, and approved it. Applies to drugs and to high-risk devices. |
| FDA cleared | A device was cleared through the 510(k) pathway by showing substantial equivalence to an existing device. This is not the same as approval. |
| FDA registered / listed | A facility told the FDA it exists and what it makes. It is an administrative filing. It implies no review of safety or effectiveness whatsoever. |
| Compounded | Prepared by a pharmacy or outsourcing facility. Permitted to be prescribed under federal law, but not FDA approved. |
The one that does the most damage is “FDA registered.” It sounds like a credential. It is closer to a business licence — a statement that a facility filed paperwork. Marketing that presents it as a mark of quality is misleading, and it is a claim regulators recognise immediately.
Approved for what, and for whom
Approval is never general. It attaches to a specific product, at specific dosages, for a specific indication, in a defined population.
That is why the same molecule can be approved for one use and not another. Semaglutide is a familiar example: the same active ingredient is marketed under different brand names with different approved indications. A drug approved for type 2 diabetes is not thereby approved for weight loss.
Prescribing outside an approved indication — off-label use — is lawful medical practice in appropriate circumstances. Marketing a drug for an unapproved use is a different matter entirely. A physician may exercise judgment; a website advertising the unapproved use is promoting it.
Compounded is not approved
Compounded preparations are not FDA-approved drugs. They are permitted under specific statutory pathways, but no agency reviewed that formulation for safety and effectiveness.
That does not make compounding illegitimate — it serves real clinical needs. It does mean that describing a compounded preparation as “FDA approved,” or implying equivalence to the branded product, is inaccurate.
The honest formulation is straightforward: “Compounded drugs are permitted to be prescribed under federal law but are not FDA approved.”
“Research use only” is not a loophole
A growing category of products is sold to clinics and consumers labelled “for research use only” or “not for human consumption.” The label is doing legal work for the seller, not for you.
Research-grade active ingredients are not permitted for use in human drugs. If a substance arrives with that label and is then administered to a patient, the label does not protect the person who administered it. It mostly documents that everyone involved knew.
Claims that create exposure
- “FDA approved” applied to a compounded preparation. Inaccurate on its face.
- “FDA registered” presented as a quality mark. Misleading.
- “Clinically proven” without the study. If you cannot produce it, do not say it.
- Efficacy figures without their population. A trial average detached from its inclusion criteria and adherence conditions is not your patient’s expectation.
- Guaranteed outcomes. “Lose 20 pounds guaranteed” is an advertising problem and a clinical one.
- Before-and-after imagery without disclosure. Individual results vary, and the images should say so.
- Brand names used to sell something else. Advertising a branded drug and dispensing a compounded alternative invites both regulatory and trademark problems.
How to write it correctly
A pattern that holds up:
“[Product] is FDA approved for [specific indication] in [population]. It is available only by prescription, and only if a licensed provider determines it is appropriate for you after an evaluation. Individual results vary. See full Prescribing Information.”
And for compounded preparations:
“This is a compounded preparation. Compounded drugs are permitted to be prescribed under federal law but are not FDA approved.”
Neither sentence costs conversions. Both are the difference between a page you can defend and one you cannot.
Where MDside sits
We review the clinical claims on the pages our practices publish, because marketing copy is a compliance surface. If your site says something a provider cannot stand behind, that is a clinical problem wearing a marketing costume.
See what is included, or read about why retatrutide cannot be legally compounded.
Frequently asked questions
What is the difference between FDA approved and FDA cleared?
Approval follows a review of safety and effectiveness data for a specific indication. Clearance is a device pathway based on substantial equivalence to an existing device. They are different standards.
Does “FDA registered facility” mean the product is safe?
No. Registration is an administrative filing stating that a facility exists and what it produces. It involves no review of safety or effectiveness.
Are compounded medications FDA approved?
No. They may be lawfully prescribed under specific pathways, but they are not FDA-approved products and should never be marketed as though they were.
Can I prescribe off-label?
Off-label prescribing is lawful medical practice in appropriate circumstances. Marketing a drug for an unapproved indication is a separate question and carries real risk.
What about “research use only” peptides?
That labelling does not create a lawful path to administer a substance to patients. Research-grade ingredients are not permitted in human drugs.
General information about FDA terminology and advertising claims, not legal advice. Confirm your specific marketing claims with healthcare counsel.